EuroScience.Net

This week in European sciences -- week 17|2004
 

Süddeutsche Zeitung asks whether Darwin isn't taught at Italian schools any longer. Die Zeit on the establishment of a central European database for medical studies. The Daily Telegraph on good story writing by Richard Dawkins. FAZ about mapping the genome, questioning climate modelling and the architecture of supra-molecular polymers. Dagens Nyheter about a Swedish debate about fundamental and applied research. FAZ about the search for planets of distant stars. Dagens Nyheter on tissue sampling in prostate cancer treatment. Der Spiegel about the rebirth of analog electronics. Dagens Nyheter with a piece about game addiction. Svenska Dagbladet about genetic engineering of sheep improving wool production. Science on the U.S. BioShield project and potential benefits for drug development against infectious diseases. In addition: NY Times on M.R.I. profiling of politics on the brain.


Special Feature
Philippe Busquin (EU)
about his services' interest in nanotechnology
>> debate on nanotechnology
>> former issues

feedback
subscribe
unsubscribe
 
 
 

Italian Trouble about Teaching Darwin at School

Scientists criticized the new Italian school schedule that failed to mention explicitely Darwin's theory of evolution to be teached for pupils of age nine to 12, reports Christiane Kohl in Süddeutsche Zeitung (April 23, 2004). The Italian scientific community is worried that politicians might try to ban evolution by a back door. But Kohl stresses that the approach is rational in the sense of the recent educational reform: more hands-on teaching, more workshop scenarios which enhance discussions and decline worthless reiterating. In their first year main focus is on computer science, engineering, mathematics and english - doesn't sound like a fall-back into the middle ages.

 

 

Süddeutsche Zeitung
April 23, 2004

Europe Gets a Medical Database

When a German doctor or patient wants to update himself on ongoing clinical studies about a certain disease or treatment, he hasn't any chance to do so, states Harro Albrecht in 'Die Zeit' (April 22, 2004). All modern databases in Europe are sketchy. This has a whole bunch of reasons: The first and important one is the economic interest of the pharmaceutical companies. They carry out a lot of studies but don't publish the results. Second, all players in the 'pharma-game' are afraid of industrial espionage. And third, negative results are published rarely. If there is a central database a lot of patients could be treated better according to the author - because numerous researchers develop "new" treatments with negative outcome that already has been tested before. The EU got aware of the problem. Starting in May, the new database on ongoing European studies will be established. In the database all clinical trials are going to be registered. But this good idea won't have any consequences, states the author: The database is secret and will be closed for public and researchers.
 

 

Die Zeit
April 22, 2004

Writing Good Stories

Richard Dawkins on science writing in The Daily Telegraph (April 21, 2004*). He gives some advice to writing scientists and journalists quoting Einstein: "Everything should be as simple as possible, but no simpler." What Einstein meant to physic's theories, Dawkins extends it to writing stories. "Don't shrink from choosing the exact word that says it best, even if it drives your reader to the dictionary." Not everybody would agree here. Further: "Seek to enlighten and inspire, not impress" - agreed. Further advice: Work on your own style, "I hate it when editors belabour me with their schoolarm rules."
* a free registration is required

 

 

The Daily Telegraph
April 21, 2004

Mapping Genome Activities

It is reported in FAZ (April 21, 2004) that an international collaboration of 152 scientists out of 40 countries map humane genome activities in a database that is free accessible on the Internet.
Joachim Müller-Jung, science editor with the FAZ, criticizes the scope and predictions of climate modelling - especially the new hyphe of earth-system-modelling. Some features have a surrealistic intention to the author, like Salvator Dalis bonmot "I like remembering the future".
Uta Bilow reports about a research team at the University of Strasbourg, France, which
studies the chemistry of supra-molecular polymers and their architecture on a nanometer scale. The team is located near to Nobel laureate Jean-Marie Lehn and funded by some kind of joint venture between the University and the German chemical giant BASF.
 

 

Frankfurter Allgemeine Zeitung
April 21, 2004

Swedish Controversy on Need-Driven Research

The call for a stronger control of fundamental research in Sweden by economic needs by industry-biased contributors to Dagens Nyheter has led to strong reactions. A group of researchers and administrators connected to the Royal Academy of Sciences fervently deny the factual basis underlying the demand (April 20, 2004). They point out that state support for need-directed research is at the same level as 25 years ago. They further argue that there is no evidence for the claim that most innovations with economic relevance were the result of need-driven research. Also three representatives of the Swedish Research Council (Vetenskapsrådet) join the counterattack (April 20, 2004). They confirm that state sponsored, need-driven research has remained constant over the past two decades. The issue is also taken with the demand that large research institutes should be strengthened. The authors of the reply contend that this is unnecessary: American biotech industry has managed very well without intermediaries such as research parks and large-scale institutes outside universities.
 

 

Dagens Nyheter
April 20, 2004

Politics on the Brain

"To put a bit more science in political science," researchers at University of California, Los Angeles, followed the brain activities of test persons inside an M.R.I. apparatus while watching campaign commercials. According to John Tierney in the New York Times (April 20, 2004) "the have already noticed intriguing patterns in how Democrats and Republicans look at candidates." The tests have to get finished until conclusions are drawn, but scientists are sure that M.R.I. technology offers a powerful tool. Anyway, "there are so many kinds of images and other stimuli in a political commercial that it's notoriously difficult for any kind of research to pinpoint effects."
 

 

New York Times
April 20, 2004

Super-Wasp Watches For New Planets

Günter Paul reports in FAZ (April 19, 2004) about efforts of Spanish and British astronomers to discover even more planets spinning around distant stars. Generally, two measurement methods are used by scientists. First, the Doppler shift which is a measure for tumbling stars forward and back by a surrounding planet. The received light is thus shifted in frequency. Second, a small decrease in the intensity of light received when a planet moves through the line of sight from earth to the distant star. The project "Super-WASP" (short for Wide Angle Search for Planets) just uses the latter method. Four telescopes started duty last week at Las Palmas operated by astronomers from Queen's University Belfast and the University of St. Andrews, Scotland. The telescopes are rather small compared to others because not maxium resolution is the issue but very tiny changes in the light intensity from a star. The angle of aperture is about 8 degrees to scan wide streches of the night sky.
 

 

Frankfurter Allgemeine Zeitung
April 19, 2004

Biobank may help Prevent Biopsies of Prostate Cancer Patiens

Chunde Li, researcher at the Karolinska Institute in Stockholm is pioneering the use of gene microarrays to diagnose prostate cancer more reliably, writes Gunilla Eldh in Dagens Nyheter (April 19, 2004). A cooperation between Stanford University and the Stockholm institute makes use of a unique collection of tissue samples from prostate cancer patients, which were collected since the middle of the 80's. The researchers hope that they can characterize a unique gene activity profile of the cancer cells and that painful biopsies will become more rare.
 

 

Dagens Nyheter
April 19, 2004

Analogue Bites Back

In the digital age it's suprising to learn that large amounts of electronics equipment depends on analogue circuitry. As Hilmar Schmundt writes in Der Spiegel (April 19, 2004) about 15 to 50 percent of IC's in gadgets from cameras to mobile phones are analogue chips. Engineers use them, first to avoid conversion of signals into bits and bytes, also analogue chips need up to 90 percent less power for processing data. Hence, "analog is cool again", according to Wired magazine.
 

 

Der Spiegel
April 19, 2004

Game Addiction and Brain Activity

Approximately 4 percent of the Swedish population develop addictive gaming behaviour during their lifetime. Per Snaprud reports in Dagens Nyheter (April 18, 2004) about new research that shows how game addiction is reflected in brain activity and how the affliction is attempted to be cured. Game addicts show an unusual low activity in the frontal lobes, where impulsive behaviour is controlled. Yale University's Mark Potenza claims that the brains of all persons may be affected in the same way by the temptation of games, but that most people have efficient mechanism that suppress the gaming urges. Current therapeutic attempts to control game addiction include cognitive behavioural therapy and even pharmaceutical interventions. The American psychiatrist John Grant has successfully tested the medicament "Revia", which is usually used to prevent relapses in alcoholics, with game addicts. It remains though still contentious if game addiction can be compared to alcoholism and other drug addictions. Some researchers claim that it has more in common with other compulsive behaviours like pyro- and kleptomania. One problem is that there is no good animal model for game addictions - laboratory rats can simply not be tempted by any "game" to become addicted.
 

 

Dagens Nyheter
April 18, 2004

Genetic Engineering in Wool Production

Thousands of years of domestication have led many sheep races to keep their woollen coat - wild sheep replace their coat regularly like many other mammals. This trait has been suppressed during domestication so that humans can "harvest" the wool by shearing the sheep. In order to save work and - so it is claimed - to avoid the stress of shearing the Australian company "Bioclip" enlists the help of a protein, reports Bengt Jonsson in Svenska Dagbladet (April 18, 2004). Australian researchers have identified a protein that leads the sheep to shed all its hair in a very short time. Sheep are covered in net, get an injection of the protein and after a short time all the shed hair are collected in the net. This methods leads to high-quality - but still expensive - wool: all wool fibers are of a similar length and not cut into pieces of different lengths and there are no skin pieces that contaminate the wool. The acceptance of the technique in Australia so far has been mixed. Some fear that the Australian sheep industry will have to confront consumer fears like the ones directed at GMOs. Other wool producers, who first were suspicious of the technique, changed their mind quickly after trying it out. The Swedish veterinary Olof Schwan thinks that it is unlikely that the technique will make it to Sweden. Swedish sheep are mainly used for meat production. And Schwan also doubts that the new technique leads to a stress reduction: the sheep don't have to be handled before and during the shearing, but they still need to be handled when they are covered with the wool-collecting net.
 

 

Svenska Dagbladet
April 18, 2004

An Uncertain Call Against Infectious Diseases

Claire M. Fraser stressed in an editorial in Science magazine (April 16, 2004*) the well-known fact that there is a lack on drugs and drug development against infectious diseases. He is director of the Rockville-based institute for genomic research, U.S., and put lots of hope in the government funded BioShield project. BioShield is meant to improve measures against possible bioterrorist attacks, but - according to Fraser - could also give drug development against new and re-emerging diseases a fresh boost. "In the current economic climate, without such an incentive it is almost certain that no company would heed the government's call to arms and shift gears to focus on infectious disease research," writes Fraser.
* a free registration is required
 

 

Science
April 16, 2004

Feedback

We are glad to receive your comments! Send us an e-mail | subscribe | unsubscribe